Company Filing History:
Years Active: 2000
Title: Innovations of Jong Sok Ahn in Immunosuppressive Agents
Introduction
Jong Sok Ahn is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the use of natural compounds as immunosuppressive agents, which has important implications for medical treatments.
Latest Patents
Jong Sok Ahn holds a patent titled "Use of rosmarinic acid and derivatives thereof as an immunosuppressant." This invention relates to the application of rosmarinic acid and its derivatives as immunosuppressive agents and inhibitors of SH2 domain function. The patent reveals that rosmarinic acid specifically inhibits the binding of ligand peptides to the Lck SH2 domain, disrupts Lck-mediated signal transduction in T cells, inhibits cytokine gene expression, and suppresses immune responses in transplanted tissues. These properties suggest that rosmarinic acid and its derivatives could be effective in treating, preventing, and diagnosing graft rejection, graft-versus-host disease (GVHD), autoimmune diseases, and inflammatory conditions. Jong Sok Ahn has 1 patent to his name.
Career Highlights
Jong Sok Ahn is affiliated with the Mogam Biotechnology Research Institute, where he conducts his research. His work has garnered attention for its potential applications in therapeutic settings, particularly in the realm of immunosuppression.
Collaborations
Some of his notable coworkers include Eun Mi Hur and Young Bong Choi, who contribute to the research efforts at the Mogam Biotechnology Research Institute.
Conclusion
Jong Sok Ahn's innovative work in the field of immunology, particularly through his patent on rosmarinic acid, highlights the potential of natural compounds in medical applications. His contributions are paving the way for advancements in the treatment of various immune-related conditions.